BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26823497)

  • 1. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry.
    Wolodimeroff E; Garg P; Swift AJ; Fent G; Lewis N; Rogers D; Charalampopoulos A; Al-Mohammad A
    Open Heart; 2022 Jun; 9(1):. PubMed ID: 35649572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic Cardiomyopathy Predicts Thromboembolism and Heart Failure in Patients With Nonvalvular Atrial Fibrillation - A Prospective Analysis From the Hokuriku-Plus AF Registry.
    Tsuda T; Hayashi K; Kato T; Kusayama T; Nakagawa Y; Nomura A; Tada H; Usui S; Sakata K; Kawashiri MA; Fujino N; Yamagishi M; Takamura M;
    Circ J; 2023 Nov; 87(12):1790-1797. PubMed ID: 37866911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study.
    Gómez Doblas JJ; Cepeda-Rodrigo JM; Agra Bermejo R; Blanco Labrador E; Blasco MT; Carrera Izquierdo M; Lekuona I; Recio Mayoral A; Rafols C; Manito N
    Clin Cardiol; 2023 Nov; 46(11):1390-1397. PubMed ID: 37596723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.
    Hernandez AF; Hammill BG; O'Connor CM; Schulman KA; Curtis LH; Fonarow GC
    J Am Coll Cardiol; 2009 Jan; 53(2):184-92. PubMed ID: 19130987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.
    Dobre D; Zannad F; Keteyian SJ; Stevens SR; Rossignol P; Kitzman DW; Landzberg J; Howlett J; Kraus WE; Ellis SJ
    Eur Heart J; 2013 Aug; 34(29):2271-80. PubMed ID: 23315907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis.
    Karwath A; Bunting KV; Gill SK; Tica O; Pendleton S; Aziz F; Barsky AD; Chernbumroong S; Duan J; Mobley AR; Cardoso VR; Slater K; Williams JA; Bruce EJ; Wang X; Flather MD; Coats AJS; Gkoutos GV; Kotecha D;
    Lancet; 2021 Oct; 398(10309):1427-1435. PubMed ID: 34474011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.
    Bucci T; Romiti GF; Shantsila A; Teo WS; Park HW; Shimizu W; Corica B; Proietti M; Tse HF; Chao TF; Frost F; Lip GYH;
    J Am Heart Assoc; 2024 Apr; 13(7):e032785. PubMed ID: 38533983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between emerging measures of heart failure processes of care and clinical outcomes.
    Hernandez AF; Hammill BG; Peterson ED; Yancy CW; Schulman KA; Curtis LH; Fonarow GC
    Am Heart J; 2010 Mar; 159(3):406-13. PubMed ID: 20211302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?
    Uijl A; Koudstaal S; Stolfo D; Dahlström U; Vaartjes I; Grobbee RE; Asselbergs FW; Lund LH; Savarese G
    J Card Fail; 2024 Apr; 30(4):541-551. PubMed ID: 37634573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and ventricular arrhythmias in patients on d,l-sotalol for rhythm control of atrial fibrillation: A nationwide cohort study.
    Lenhoff H; Järnbert-Petersson H; Darpo B; Tornvall P; Frick M
    Heart Rhythm; 2023 Nov; 20(11):1473-1480. PubMed ID: 37598987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps.
    Triska J; Tamargo J; Bozkurt B; Elkayam U; Taylor A; Birnbaum Y
    Cardiovasc Drugs Ther; 2023 Dec; 37(6):1205-1223. PubMed ID: 35357604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers in Hypertensive Left Ventricular Hypertrophy and Atrial Fibrillation Prevention.
    Koraćević G; Mićić S; Stojanović M; Zdravkovic M; Simić D; Kostić T; Atanasković V; Janković-Tomašević R
    Curr Vasc Pharmacol; 2024; 22(1):19-27. PubMed ID: 38031765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from The Retrospective Evaluation and Assessment of Therapies in AF study.
    Ullal AJ; Than CT; Fan J; Schmitt S; Perino AC; Kaiser DW; Heidenreich PA; Frayne SM; Phibbs CS; Turakhia MP
    Am Heart J; 2015 Nov; 170(5):1033-1041.e1. PubMed ID: 26542514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Atrial Fibrillation on Heart Failure in Patients Treated With Anthracycline Chemotherapy.
    Onoue T; Kang Y; Lefebvre B; Smith AM; Denduluri S; Fradley MG; Chittams J; Carver JR; Scherrer-Crosbie M
    Am J Cardiol; 2024 Jan; 211():268-274. PubMed ID: 37984640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a nomogram model for all-cause mortality risk in patients with chronic heart failure and atrial fibrillation.
    Guan L; Wang CH; Sun H; Sun ZJ
    BMC Geriatr; 2024 May; 24(1):470. PubMed ID: 38811919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac adrenergic control and atrial fibrillation.
    Workman AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):235-49. PubMed ID: 19960186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-Blockers, Digoxin, or Both Following an Incident Diagnosis of Atrial Fibrillation: A Prospective Cohort Study.
    Brophy JM; Nadeau L
    Can J Cardiol; 2023 Nov; 39(11):1587-1593. PubMed ID: 37331622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study.
    Ahl R; Matthiessen P; Sjölin G; Cao Y; Wallin G; Ljungqvist O; Mohseni S
    BMJ Open; 2020 Jul; 10(7):e036164. PubMed ID: 32641361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of atrial fibrillation and heart failure in hospitalized patients: A real-world survey in a nationwide snapshot.
    Iliodromitis K; Tzeis S; Xintarakou A; Pyrgakis V; Zarifis I; Patsilinakos S; Draganigos A; Triposkiadis F; Hahalis G; Karanasios A; Goudevenos I; Michalis L; Karvounis C; Parthenakis F; Kanakakis I; Tousoulis D; Iliodromitis E; Vardas P
    Hellenic J Cardiol; 2023; 74():18-23. PubMed ID: 37141945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.